Efficacy and Safety of Once-Weekly Semaglutide Versus Once-Daily Sitagliptin as an Add-On to Metformin, Thiazolidinediones, or Their Combination in Patients With Type 2 Diabetes (SUSTAIN 2): A 56-Week, Double-Blind, Phase 3a, Randomized Trial
In the Tirzepatide versus Semaglutide cohort of 25,060 matched pairs, no statistically significant differences emerged across ocular outcomes, though Tirzepatide showed a non-significant trend (HR 0.87, 95% CI: 0.551.37, p = 0.540
NAD+ therapy may be particularly helpful for: Professionals experiencing chronic stress and burnout Individuals with fatigue, brain fog, or poor focus People struggling with mood swings or mild depression Those recovering from substance use disorders or post-illness fatigue Its important to consult a qualified healthcare provider to ensure NAD+ therapy is safe and appropriate for your specific needs
Therefore, Boggio et al
Apply for Your Assessment How Body Balance Medical Supports GLP-1 Patients Dietary information is useful
Potential Serious Side Effects and Complications include, but are not limited to: Gastroparesis and chronic gastrointestinal issues (constipation and/or diarrhea) Thyroid C-cell tumor and Medullary thyroid cancer Hypersensitivity reaction, Anaphylaxis and/or Angioedema Acute kidney injury and chronic renal failure exacerbation
